Bayer backs Iberogast against safety attacks
This article was originally published in OTC Bulletin & The Rose Sheet
Executive Summary
Bayer Consumer Health has defended its decision not to include warnings about possible liver-damage when taking its herbal gastrointestinal product Iberogast, after harsh criticism from German Member of Parliament (MP) Kordula Schulz-Asche.